期刊
GENE
卷 777, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.gene.2021.145471
关键词
Mesenchymal stem cells; Covid 19; Treatment; Tissue regeneration
资金
- Mazandaran University of Medical Sciences, Sari, Iran [8177]
The emergence of the new coronavirus has raised concerns about health issues and long-term effects after patient recovery. Researchers are exploring cell-based therapy, particularly the use of MSCs, due to their immunomodulatory properties and proven therapeutic effects. Practical guidelines are needed for the use of MSCs in clinical trials.
In addition to causing health concerns, the new coronavirus has been considered in the world with its unknown mechanism of physiopathogenesis and long-term effects after patient recovery. Pulmonary, renal, hepatic and cardiac complications have been reported so far. Beside the researchers' focus on finding vaccines and using conventional therapies, cell-based therapy might be an effective therapeutic strategy. The use of mesenchymal stem cells (MSCs) is one of the options due to their immunomodulatory properties and their proven effects in the treatment of many diseases. As MSCs are not infected with covid-19, there is evidence that it modulates the immune system and prevents the virus from clotting. Despite the beginning of numerous clinical trials in the use of mesenchymal stem cells, it is necessary to set a practical guideline that specifies items such as cell origin, number of cells, frequency of injection, injection site, etc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据